What happened in optometry this week: March 11 - March 15

Blog
Article

Catch up on what happened in optometry during the week of March 11-March 15.

Catch up with what Optometry Times shared this week:

Phase 2b trial complete for OAG drug-eluting contact lens from MediPrint Ophthalmics

By Martin David Harp, Associate Editor, Ophthalmology Times

MediPrint Ophthalmics has announced the completion of its glaucoma SIGHT-2, phase 2b study evaluating their LL-BMT1 versus a control group on bimatoprost 0.01% ophthalmic solution. The active-controlled, randomized, dose-finding, multi-center study evaluated the safety and efficacy of LL-BMT1 in 28 patients diagnosed with open-angle glaucoma for 3 weeks.

Read here...

Lessons learned from COVID-19: How to prepare for the next public health emergency

By Cynthia P. Ruggeiro, OD, MPH, FAAO, and Heidi Sutter, OD, MPH

Since its emergence in late 2019, the SARS-CoV-2 virus has changed lives and livelihoods and raised our awareness of the potential for circulating pathogens to disrupt our world. Although COVID-19 is still with us, we are removed enough from the early days of widespread uncertainty to start assessing what we have learned.

Read here...

Turning inexperience into expertise in fitting scleral lenses

By Jeffrey Sonsino, OD, FAAO, and Julie Lafreniere, OD, FAAO

Scleral lenses demand expertise. We can cause real harm by placing a hard piece of plastic on soft tissue. Although they require time to fit and are difficult to troubleshoot when problems arise, scleral lenses are life-changing for our patients.

Read here...

You and Eye: What optometrists need to know about low vision

By Miriam Korik, OD, and Emily Kaiser Maharjan, Assistant Managing Editor

Patrick D. Yoshinaga, OD, MPH, FAAO, professor and chief of low vision rehabilitation service at Southern California College of Optometry at Marshall B. Ketchum University joins host Miriam Korik, OD, on a deep dive into what low vision rehab entails. Assistive tech, diagnosis, occupational therapy referrals, and AI–all and more are discussed as these two experts discuss the the big picture and minutia of care for patients with low vision.

Listen here...

Organizations planning ahead with resources for total solar eclipse

By Jordana Joy, Associate Editor

A handful of organizations are already prepping for the April 8 total solar eclipse.

Prevent Blindness will be utilizing its Eclipse + Your Eyes program, which includes educational videos, materials, and toolkits for the public.1 Additionally, the American Optometric Association (AOA) is supplying materials for its member doctors and posting eye safety information to help keep the public's eyes healthy during the event.2

Read here...

Recent Videos
Danica Marrelli, OD, FAAO, at Glaucoma 360 discussing visual field testing for patients with glaucoma
Walline, OD, PhD, FAAO, states that the best way to learn the benefits of artificial intelligence for your practice is to stay on top of continuing education attendance.
Jeffrey Walline, OD, PhD, FAAO, gives an overview of the AAO's 2024 and what to expect in 2025 and beyond.
Dr Jamie Kuzniar discusses higher order aberrations and premium scleral lenses
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference.
© 2025 MJH Life Sciences

All rights reserved.